Enterin Inc. (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 17, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $12,700,000
Company Info
- Founders
- Michael Zasloff
- Company Description
- Enterin Inc. is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. The lead compound, ENT-01, displaces membrane-bound alpha-synuclein aggregates from nerve cells in the enteric nervous system and improves neural signaling between the gut and the brain in preclinical models of Parkinson's disease.
- Market
- Neurodegenerative Disease Treatment
- Location
- Philadelphia, PA, USA
- Coinvestors
- New Venture Partners